Formulation: A crystalline solid
Purity: ≥97%
Fatty Acid Amide Hydrolase Inhibitor Screening Assay Kit
A convenient fluorescence-
Item No. 10005196
- Anandamide Amidohydrolase 1
- FAAH
- Oleamide Hydrolase 1
- PSAB
Formulation: A crystalline solid
Purity: ≥98%
Soluble Epoxide Hydrolase (human, recombinant)
Active • Host: Insect cells • AA: 2-555 (full length) • Tag: N-terminal His • MW: 64 kDa
Item No. 10011669
Formulation: TBS, pH 7.4, with 20% glycerol
Purity: ≥95% estimated by SDS-PAGE
- Cytosolic Epoxide Hydrolase (CEH)
- EPHX2
- Epoxide Hydrolase 2
- sEH
Formulation: A solid
Purity: ≥98%
- TTX citrate
Fatty Acid Amide Hydrolase (human, recombinant)
Source: Active recombinant C-terminal His-tagged FAAH expressed in Sf21 cells • Amino acids: 2-579 • MW: 64.3 kDa
Item No. 10010183
Formulation: 20 mM Hepes, pH 7.8, with 150 mM sodium chloride, 1 mM EDTA, 1 mM DTT, 0.5% CHAPS, and 20% glycerol
Purity: Cell Lysate: Resuspended 100,000 g pellet
- Anandamide Amidohydrolase 1
- FAAH
- Oleamide Hydrolase 1
- PSAB
Formulation: A crystalline solid
Purity: ≥95%
Formulation: A crystalline solid
Purity: ≥98%
- Palmidrol
- Palmityl Ethanolamide
- PEA
iNOS (mouse, recombinant)
Active • Host: E. coli • AA: 1-1,144 (full length) • MW: 130 kDa
Item No. 60864
Formulation: 50 mM HEPES, pH 7.4, with 10% glycerol, 8 µM BH4, 0.08 mM DTT, 2% protease inhibitor cocktail (EDTA free), and 0.05% nuclease
Purity: 100,000 x g supernatant
- Hepatocyte NOS
- Inducible Nitric Oxide Synthase
- Inducible NO Synthase
- Inducible NOS
- Nitric Oxide Synthase 2
- NOS II
- hep-NOS
Immunogen: Purified iNOS from cytokine-induced RAW 264.7 mouse macrophages
Host: Rabbit
Applications: IHC, IP, WB
Formulation: A solid
Purity: ≥98%
- Araregai Toxin
- Maculotoxin
- Tectin
- TTX
Formulation: A crystalline solid
Purity: ≥98%
- SR141716
Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit
A convenient fluorometric method of screening human sEH inhibitors
Item No. 10011671
- Cytosolic Epoxide Hydrolase (CEH)
- EPHX2
- Epoxide Hydrolase 2
- sEH
Monoacyl
A colorimetric method for screening MAGL inhibitors
Item No. 705192
- MAGL
- MGL
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥98%
- (±)19,20 EDP
- (±)19,20-epoxy Docosapentaenoic Acid
- (±)19,20-epoxy DPA
- (±)19,20-EpDPE
Formulation: A crystalline solid
Purity: ≥98%
- DuP-
753 - MK 954
Formulation: 50 mM HEPES, pH 7.4, with 100 mM sodium chloride, 5 mM MgCl2, 0.1% CHAPS, and 25% glycerol
Purity: ≥90% estimated by SDS-PAGE
- MAGL
- MGL
Formulation: A crystalline solid
Purity: ≥98%
Formulation: A crystalline solid
Purity: ≥98%
- Ro 1138452
Formulation: A crystalline solid
Purity: ≥98%
Formulation: A crystalline solid
Purity: ≥98%
AM630
An inverse agonist at CB2 and partial agonist at CB1 receptors
CAS No. 164178-33-0
Item No. 10006974
Formulation: A crystalline solid
Purity: ≥98%
- 6-Iodopravodoline
Gabapentin-d4
An internal standard for the quantification of gabapentin
CAS No. 1185039-20-6
Item No. 18254
Formulation: A solid
Purity: ≥95%
Immunogen: Synthetic peptide from the C-terminal region of rat FAAH
Host: Rabbit
Applications: IHC and WB
Formulation: A crystalline solid
Purity: ≥98%
- SC-
58635 - YM-
177
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
